Christoph Lengauer, PhD
On The Move: Who’s Going Where In Biopharma And Medtech Start-Ups
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
More from Archive
More from Scrip
• By
The updated US FDA label modifies dose titration based on TRAILBLAZER-ALZ 6, a study that showed a more gradual rise in dosing levels reduced ARIA-E incidence without reducing amyloid clearance.
• By
Joshi joins the parent company of Citeline, which houses flagship publications Scrip and Pink Sheet, to focus on AI, business harmonization and long-term growth.
• By
From vonoprazan and inclisiran to nirsevimab, big pharma has licensed several products to Indian firms as have other biopharma players. Experts discuss the intricacies of such licensing deals amid signs of more action in store and whether geopolitics could dull partnering with Chinese firms.